Trial NCT00436748

View at ClinicalTrials.gov 
Org. Study IDs: 20050256

Last trial update was posted on 2022-11-29

MeSH Interventions

Darbepoetin alfa

MeSH Conditions

Anemia Kidney Diseases Renal Insufficiency, Chronic

Other Conditions

Chronic Kidney Disease Kidney Disease

Stopping Reasons

FDA and EMA agreed that the information that had been submitted to date was acceptable to meet the requirements of the post-marketing commitment.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID